Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer.
Sci Rep
; 10(1): 20412, 2020 11 23.
Article
in En
| MEDLINE
| ID: mdl-33230143
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Transcription Factors
/
Nuclear Proteins
/
Gene Expression Regulation, Neoplastic
/
DNA Helicases
/
Enhancer of Zeste Homolog 2 Protein
/
Carcinoma, Ovarian Epithelial
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Aged80
Language:
En
Journal:
Sci Rep
Year:
2020
Document type:
Article
Affiliation country:
Austria